中 | EN

News & Trends

Home News & Trends Special Reports Back

Subject Recruitment Advertisement for Phase III Clinical Study of Therapeutic (Synthetic Peptide) Hepatitis B Vaccine (NHT210118)

Time：2021-12-09 02:44:03 hits：10294



Recommended reading

  • Novel Peptide Bioscience Co., Ltd. Acquires Jiangsu Mendel Gene Technology Co., Ltd.

  • Subject Recruitment Advertisement for Phase III Clinical Study of Therapeutic (Synthetic Peptide) Hepatitis B Vaccine (NHT210118)